Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 1-deamino-8-d-arginine Vasopressin
2. 1-desamino-8-arginine Vasopressin
3. Acetate, Desmopressin
4. Adiuretin
5. Adiuretin Sd
6. Apo-desmopressin
7. Arginine Vasopressin, Deamino
8. Ddavp
9. Deamino Arginine Vasopressin
10. Desmogalen
11. Desmopressin
12. Desmopressin Monoacetate
13. Desmopressin Monoacetate, Trihydrate
14. Desmopressine Ferring
15. Desmospray
16. Desmotabs
17. Ferring, Desmopressine
18. Minirin
19. Minurin
20. Monoacetate, Desmopressin
21. Monoacetate, Trihydrate Desmopressin
22. Nocutil
23. Octim
24. Octostim
25. Trihydrate Desmopressin Monoacetate
26. Vasopressin, 1-deamino-8-d-arginine
27. Vasopressin, 1-desamino-8-arginine
28. Vasopressin, Deamino Arginine
1. Octostim
2. Minirin
3. Ddavp
4. Stimate
5. Concentraid
6. Desmopressin Acetate Anhydrous
7. Noctiva
8. 62288-83-9
9. Ddavp (needs No Refrigeration)
10. Desmospray
11. Anhydrous Desmopressin Acetate
12. Desmopressin Acetate Preservative Free
13. Desmopressin Acetate (needs No Refrigeration)
14. 1k12647sfc
15. Desmopressin Acetate Hydrate
16. Desmotabs
17. Minirine
18. Nocutil
19. Octim
20. Desmopressin Acetate Trihydrate
21. Demopressin Acetate
22. Ddavp Nasal Spray
23. Ddavp Rhinal Tube
24. Stimate Nasal Spray
25. Noqdirna
26. Presinex
27. Desmomelt
28. Unii-1k12647sfc
29. Desmopressin Acetate [usan:jan]
30. Chembl1200556
31. Dtxsid4046864
32. 16679-58-6(free Base)
33. Desmopressin Acetate [mi]
34. Stimate (needs No Refrigeration)
35. Ex-a4285
36. 1-(3-mercaptopropionic Acid)-8-d-arginine Vasopression Monoacetate
37. Bdbm50247923
38. Mfcd00133962
39. Akos025311518
40. Ccg-270644
41. Desmopressin Monoacetate Anhydrous
42. Anhydrous Desmopressin Acetate [mart.]
43. (deamino-cys1,d-arg8)-vasopressin Acetate
44. 789d983
45. Q27252517
46. 1-(3-mercaptopropionic Acid)-8-d-arginine-vasopressin Monoacetate (salt)
47. Vasopressin, 1-(3-mercaptopropanoic Acid)-8-d-arginine-, Monoacetate (salt)
48. Vasopressin,1-(3-mercaptopropanoic Acid)-8-d-arginine-,monoacetate(salt)(9ci)
| Molecular Weight | 1129.3 g/mol |
|---|---|
| Molecular Formula | C48H68N14O14S2 |
| Hydrogen Bond Donor Count | 14 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 19 |
| Exact Mass | 1128.44808525 g/mol |
| Monoisotopic Mass | 1128.44808525 g/mol |
| Topological Polar Surface Area | 526 Ų |
| Heavy Atom Count | 78 |
| Formal Charge | 0 |
| Complexity | 2070 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Desmopressin acetate |
| Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
| Active Ingredient | Desmopressin acetate |
| Dosage Form | Injectable; Spray, metered; Tablet; Solution |
| Route | Nasal; oral; Injection; Oral |
| Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
| 2 of 2 | |
|---|---|
| Drug Name | Desmopressin acetate |
| Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
| Active Ingredient | Desmopressin acetate |
| Dosage Form | Injectable; Spray, metered; Tablet; Solution |
| Route | Nasal; oral; Injection; Oral |
| Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
| Market Status | Tentative Approval; Prescription |
| Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
Antidiuretic Agents
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-06
Pay. Date : 2012-12-03
DMF Number : 16947
Submission : 2003-11-07
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2309
Submission : 1974-03-15
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8093
Submission : 1989-06-07
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7493
Submission : 1988-04-30
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9386
Submission : 1991-10-24
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8396
Submission : 1990-01-26
Status : Active
Type : II

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9053
Submission : 1991-04-11
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8044
Submission : 1989-04-26
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for pharmaceutical and biotech industries. LGM also operates as a full-service CDMO, offering formulat...
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development ...
About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
About the Company : Omgene Life Sciences Pvt. Ltd. is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integ...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...
About the Company : ApiSyn Healthcare, established in 2017, is a vertically integrated manufacturer of APIs & intermediates serving the global pharmaceutical industry. As part of SynZeal Research, a p...
About the Company : BCN Peptides is a privately own company completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications. We are a customer oriented...

About the Company : Piramal Pharma Solutions (PPS) is a CDMO that provides end-to-end solutions for drug development and manufacturing across the drug life cycle to its clients in North America, Europ...

About the Company : ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a w...

About the Company : Smaart Pharmaceutticals consciously strive for innovation through newer technologies, modern equipment available betterment of life and bring newer products for its customer. Smaa...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Dosage Form : Capsule, Tablet, Topical Film, Transdermal Patch
Grade : Not Available
Category : Controlled & Modified Release, Direct Compression, Granulation
Application : Controlled & Modified Release, Direct Compression, Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Lauryl Sulfate
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
Application : Granulation
Excipient Details : Crospovidone is used as a granulating agent in pharmaceutical formulations such as tablets, granules, and pellets.
Dosage Form : Granule / Pellet, Tablet
Grade : Not Available
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Excipient Details : Tablets, Granules, Pills, Disintegrants and fillers.
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Brand Name : Sheffield™ Monohydrate 313
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Application : Fillers, Diluents & Binders, Granulation
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle...
Ingredient(s) : Lactose Monohydrate
Excipients Web Link
Brand Name : Sheffield™ Monohydrate 310
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Brand Name : Sheffield™ Monohydrate 312
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Application : Direct Compression, Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2030-06-15
US Patent Number : 9539302
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201656
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2030-06-15
US Patent Number : 11419914
Drug Substance Claim :
Drug Product Claim :
Application Number : 201656
Patent Use Code : U-3431
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2030-06-15
US Patent Number : 9539302
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201656
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2030-06-15
US Patent Number : 11419914
Drug Substance Claim :
Drug Product Claim :
Application Number : 201656
Patent Use Code : U-3431
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2030-06-15
US Patent Number : 12090190
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201656
Patent Use Code : U-4003
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2030-06-15
US Patent Number : 12090190
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 201656
Patent Use Code : U-4003
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-15

Patent Expiration Date : 2029-05-21
US Patent Number : 10137167
Drug Substance Claim :
Drug Product Claim :
Application Number : 22517
Patent Use Code : U-2327
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-21

Patent Expiration Date : 2030-04-13
US Patent Number : 9974826
Drug Substance Claim :
Drug Product Claim :
Application Number : 22517
Patent Use Code : U-2326
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-04-13

Patent Expiration Date : 2029-05-21
US Patent Number : 11020448
Drug Substance Claim :
Drug Product Claim :
Application Number : 22517
Patent Use Code : U-2327
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-05-21

Patent Expiration Date : 2030-04-13
US Patent Number : 9974826
Drug Substance Claim :
Drug Product Claim :
Application Number : 22517
Patent Use Code : U-2327
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-04-13

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Desmopressin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Desmopressin Acetate manufacturer or Desmopressin Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Desmopressin Acetate manufacturer or Desmopressin Acetate supplier.
PharmaCompass also assists you with knowing the Desmopressin Acetate API Price utilized in the formulation of products. Desmopressin Acetate API Price is not always fixed or binding as the Desmopressin Acetate Price is obtained through a variety of data sources. The Desmopressin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Desmopressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Desmopressin, including repackagers and relabelers. The FDA regulates Desmopressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Desmopressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Desmopressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Desmopressin supplier is an individual or a company that provides Desmopressin active pharmaceutical ingredient (API) or Desmopressin finished formulations upon request. The Desmopressin suppliers may include Desmopressin API manufacturers, exporters, distributors and traders.
click here to find a list of Desmopressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Desmopressin DMF (Drug Master File) is a document detailing the whole manufacturing process of Desmopressin active pharmaceutical ingredient (API) in detail. Different forms of Desmopressin DMFs exist exist since differing nations have different regulations, such as Desmopressin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Desmopressin DMF submitted to regulatory agencies in the US is known as a USDMF. Desmopressin USDMF includes data on Desmopressin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Desmopressin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Desmopressin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Desmopressin Drug Master File in Japan (Desmopressin JDMF) empowers Desmopressin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Desmopressin JDMF during the approval evaluation for pharmaceutical products. At the time of Desmopressin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Desmopressin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Desmopressin Drug Master File in Korea (Desmopressin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Desmopressin. The MFDS reviews the Desmopressin KDMF as part of the drug registration process and uses the information provided in the Desmopressin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Desmopressin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Desmopressin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Desmopressin suppliers with KDMF on PharmaCompass.
A Desmopressin CEP of the European Pharmacopoeia monograph is often referred to as a Desmopressin Certificate of Suitability (COS). The purpose of a Desmopressin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Desmopressin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Desmopressin to their clients by showing that a Desmopressin CEP has been issued for it. The manufacturer submits a Desmopressin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Desmopressin CEP holder for the record. Additionally, the data presented in the Desmopressin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Desmopressin DMF.
A Desmopressin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Desmopressin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Desmopressin suppliers with CEP (COS) on PharmaCompass.
A Desmopressin written confirmation (Desmopressin WC) is an official document issued by a regulatory agency to a Desmopressin manufacturer, verifying that the manufacturing facility of a Desmopressin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Desmopressin APIs or Desmopressin finished pharmaceutical products to another nation, regulatory agencies frequently require a Desmopressin WC (written confirmation) as part of the regulatory process.
click here to find a list of Desmopressin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Desmopressin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Desmopressin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Desmopressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Desmopressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Desmopressin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Desmopressin suppliers with NDC on PharmaCompass.
Desmopressin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Desmopressin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Desmopressin GMP manufacturer or Desmopressin GMP API supplier for your needs.
A Desmopressin CoA (Certificate of Analysis) is a formal document that attests to Desmopressin's compliance with Desmopressin specifications and serves as a tool for batch-level quality control.
Desmopressin CoA mostly includes findings from lab analyses of a specific batch. For each Desmopressin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Desmopressin may be tested according to a variety of international standards, such as European Pharmacopoeia (Desmopressin EP), Desmopressin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Desmopressin USP).